Usual Care Pulmonary Rehabilitation Program
OtherParticipants in the Usual Care Pulmonary Rehabilitation Program group will complete an 8 week clinic based Pulmonary Rehabilitation Program (usual care).
NCT Number: NCT03801330
The purpose of this study is to measure the feasibility of use of a digital pulmonary rehabilitation tool compared with standard care home program pulmonary rehabilitation.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Wake Forest Baptist Health, Charlotte, North Carolina, United States
The study design is a between subjects (Usual care/App) repeated measures (pre/post) design to compare the feasibility of usual care compared with the digital app, Inspiration Point, used in the home for 8 weeks.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
for participants with COPD:
Participants in the Usual Care Pulmonary Rehabilitation Program group will complete an 8 week clinic based Pulmonary Rehabilitation Program (usual care).
Participants in the Pulmonary Rehabilitation Software-Based Home Program group will complete an 8-week home-based Pulmonary Rehabilitation Program using a software app (software)
Time frame: Change from baseline 6 Minute Walk Test score at 2 months
Measures distance walked in 6 minutes
Time frame: Change from baseline Modified Medical Research Council Dyspnea Scale (mMRC) score at 2 months
Single question questionnaire describing shortness of breath. Total Score Range from 0-4, 0 is better.
Time frame: Change from baseline VR-12 score at 2 months
Survey of health status and quality of life
From (https://www.rand.org/health-care/surveys_tools/mos/36-item-short-form/scoring.html) "Scoring the RAND 36-Item Health Survey is a two-step process. First, precoded numeric values are recoded per the scoring key given in Table 1. Note that all items are scored so that a high score defines a more favorable health state. In addition, each item is scored on a 0 to 100 range so that the lowest and highest possible scores are 0 and 100, respectively. Scores represent the percentage of total possible score achieved. In step 2, items in the same scale are averaged together to create the 8 scale scores. Table 2 lists the items averaged together to create each scale. Items that are left blank (missing data) are not taken into account when calculating the scale scores. Hence, scale scores represent the average for all items in the scale that the respondent answered."
Time frame: Change from baseline St Georges Questionnaire score at 2 months
A self-administered disease-specific instrument designed to measure the impact on overall health, daily life, and perceived well-being in patients with obstructive airways disease. The questionnaire has 50 items Scores range from 0-100, with higher scores indicating more limitations
https://www.thoracic.org/members/assemblies/assemblies/srn/questionaires/sgrq.php
Time frame: Change from baseline Lung Information Needs Questionnaire score at 2 months
The questionnaire used to identify a person with COPD's need for information about their disease. The questionnaire measures the extent to which the patient needs more information, as perceived by the patient and clinician. It is scored to produce an overall score and 6 domain scores (Disease knowledge, medicines, self-management, exercise, diet, smoking).
The score is the sum of all 6 domains with a range from 0-25. High scores indicate high information needs, a lower score is better.
Time frame: Change from baseline Software Usability Scale (SUS)score at 2 months
Measures usability and learnability of software tools. Total Score provides percentile score indicating usability/learnability. Range 0-100, Higher (100%) is better.
Time frame: Change from baseline TUG score at 2 months
Measures the time taken to stand up from a chair, walk 10 feet, turn around, and return to sitting.
Time frame: Change from baseline 30STST score at 2 months
Measures the number of times a participant can stand from a seated position in 30 seconds
Time frame: Change in 4STBT score at 2 months
Measures balance in 4 increasing more challenging positions
Time frame: Change in CAT score at 2 months
An 8 item test which measures the effect of COPD on a patient's overall health. The items on this test measure a patient's cough, sputum, breathlessness, chest tightness, confidence, activity, sleep and energy levels
Time frame: Change in DS score at 2 months
A 2 question survey which can be used to evaluate your risk of depression
Time frame: Change in CCI score at 2 months
The Charlson comorbidity index predicts the one-year mortality for a patient who may have a range of comorbid conditions, such as heart disease or cancer (a total of 22 conditions). This index is helpful to ensure the groups are equal for the study comparison and statistics.
Time frame: Change in FRQ score at 2 months
The FRQ is comprised of 13 questions about a person's history of falls and potential fall risk.
Time frame: Change in PROMIS score at 2 months
This test is a health-related quality of life questionnaire.
Time frame: Change in SILS score at 2 months
The SILS is a single item survey which determines literacy and health literacy. It is a direct assessment of a patient's need for assistance in reading health materials.
Blue Marble Rehab Inc
Industry
Inspiration Point-A Digital Pulmonary Rehabilitation Tool for Use With Self- Management Interventions
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03927820
Asthma, Bronchial Diseases
Nashville, Tennessee, United States
View Trial DetailsNCT06614959
Bronchial Diseases, Bronchitis
Montreal, Quebec, Canada
View Trial DetailsNCT04754490
COPD, Chronic Disease
Abercynon, Wales, United Kingdom
View Trial DetailsNCT06336252
Arthritis, Basal Ganglia Diseases
Copenhagen, Denmark
View Trial Details